203 related articles for article (PubMed ID: 20222752)
1. A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment.
Tarride JE; Hopkins R; Blackhouse G; Bowen JM; Bischof M; Von Keyserlingk C; O'Reilly D; Xie F; Goeree R
Pharmacoeconomics; 2010; 28(4):255-77. PubMed ID: 20222752
[TBL] [Abstract][Full Text] [Related]
2. Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus.
Asche CV; Hippler SE; Eurich DT
Pharmacoeconomics; 2014 Jan; 32(1):15-27. PubMed ID: 24357160
[TBL] [Abstract][Full Text] [Related]
3. Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013.
Charokopou M; Sabater FJ; Townsend R; Roudaut M; McEwan P; Verheggen BG
Curr Med Res Opin; 2016; 32(2):207-18. PubMed ID: 26473650
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes: A systematic review and critical appraisal of decision-analytic models.
Usman M; Khunti K; Davies MJ; Gillies CL
Diabetes Res Clin Pract; 2020 Mar; 161():108073. PubMed ID: 32061637
[TBL] [Abstract][Full Text] [Related]
5. A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus.
Henriksson M; Jindal R; Sternhufvud C; Bergenheim K; Sörstadius E; Willis M
Pharmacoeconomics; 2016 Jun; 34(6):569-85. PubMed ID: 26792792
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of interventions in diabetes: a review of published economic evaluations in the UK setting, with an eye on the future.
Tucker DM; Palmer AJ
Prim Care Diabetes; 2011 Apr; 5(1):9-17. PubMed ID: 21071296
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review.
Di Tanna GL; Bychenkova A; O'Neill F; Wirtz HS; Miller P; Ó Hartaigh B; Globe G
Pharmacoeconomics; 2019 Mar; 37(3):359-389. PubMed ID: 30596210
[TBL] [Abstract][Full Text] [Related]
9. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
[TBL] [Abstract][Full Text] [Related]
10. Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic Review.
Kirsch F
Value Health; 2016 Dec; 19(8):1039-1054. PubMed ID: 27987631
[TBL] [Abstract][Full Text] [Related]
11. Systematic methodological review of health state values in glaucoma cost-utility analyses.
Kennedy K; Sarohia G; Podbielski D; Pickard S; Tarride JE; Xie F
Eur J Health Econ; 2024 Feb; ():. PubMed ID: 38411844
[TBL] [Abstract][Full Text] [Related]
12. Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.
Dams J; Bornschein B; Reese JP; Conrads-Frank A; Oertel WH; Siebert U; Dodel R
Pharmacoeconomics; 2011 Dec; 29(12):1025-49. PubMed ID: 22077577
[TBL] [Abstract][Full Text] [Related]
13. Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence.
Zhong Y; Lin PJ; Cohen JT; Winn AN; Neumann PJ
Value Health; 2015 Mar; 18(2):308-14. PubMed ID: 25773567
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus.
Antoniou M; Mateus C; Hollingsworth B; Titman A
Pharmacoeconomics; 2024 Jan; 42(1):19-40. PubMed ID: 37737454
[TBL] [Abstract][Full Text] [Related]
15. Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations.
Tsoi B; O'Reilly D; Jegathisawaran J; Tarride JE; Blackhouse G; Goeree R
BMC Res Notes; 2015 Jun; 8():244. PubMed ID: 26081877
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of Markov models evaluating multicomponent disease management programs in diabetes.
Kirsch F
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):961-84. PubMed ID: 26535605
[TBL] [Abstract][Full Text] [Related]
17. How to Appropriately Extrapolate Costs and Utilities in Cost-Effectiveness Analysis.
Bojke L; Manca A; Asaria M; Mahon R; Ren S; Palmer S
Pharmacoeconomics; 2017 Aug; 35(8):767-776. PubMed ID: 28470594
[TBL] [Abstract][Full Text] [Related]
18. A review of simulation models for the long-term management of type 2 diabetes in low-and-middle income countries.
Mukonda E; Cleary S; Lesosky M
BMC Health Serv Res; 2021 Dec; 21(1):1313. PubMed ID: 34872555
[TBL] [Abstract][Full Text] [Related]
19. Costs and benefits associated with diabetes education: a review of the literature.
Boren SA; Fitzner KA; Panhalkar PS; Specker JE
Diabetes Educ; 2009; 35(1):72-96. PubMed ID: 19244564
[TBL] [Abstract][Full Text] [Related]
20. [Diabetes mellitus and comorbid depression: economic findings from a systematic literature review].
Lehnert T; Konnopka A; Riedel-Heller S; König HH
Psychiatr Prax; 2011 Nov; 38(8):369-75. PubMed ID: 22048882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
